Cargando…
Adverse Drug Reactions of Antihypertensives and CYP3A5*3 Polymorphism Among Chronic Kidney Disease Patients
Chronic kidney disease (CKD) patients may be more susceptible to adverse drug reactions (ADRs), given their complex medication regimen and altered physiological state driven by a decline in kidney function. This study aimed to describe the relationship between CYP3A5*3 polymorphism and the ADR of an...
Autores principales: | Lee, Fei Yee, Islahudin, Farida, Abdul Gafor, Abdul Halim, Wong, Hin-Seng, Bavanandan, Sunita, Mohd Saffian, Shamin, Md Redzuan, Adyani, Makmor-Bakry, Mohd |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8963814/ https://www.ncbi.nlm.nih.gov/pubmed/35359836 http://dx.doi.org/10.3389/fphar.2022.848804 |
Ejemplares similares
-
Effects of CYP3A5 Polymorphism on Rapid Progression of Chronic Kidney Disease: A Prospective, Multicentre Study
por: Lee, Fei Yee, et al.
Publicado: (2021) -
A Meta-Analysis on the Performance of Cystatin C- versus Creatinine-based eGFR Equations in Predicting Vancomycin Clearance
por: Mohd Tahir, Nor Asyikin, et al.
Publicado: (2020) -
Factors associated with the frequency of antihypertensive drug adjustments in chronic kidney disease patients: a multicentre, 2-year retrospective study
por: Lee, Fei Yee, et al.
Publicado: (2021) -
Prescribing Practices of Intravenous Immunoglobulin in Tertiary Care Hospitals in Malaysia: A Need for a National Guideline for Immunoglobulin Use
por: Lee, Jian Lynn, et al.
Publicado: (2022) -
Drug-Related Problems in Pulmonary Hypertension with Valvular Heart Disease
por: Abdul-Ghaffar, Farizan, et al.
Publicado: (2022)